{"DataElement":{"publicId":"3688515","version":"1","preferredName":"Malignant Neoplasm Neuroendocrine Function Assessment Type","preferredDefinition":"the type of neuroendocrine malignant neoplasm.","longName":"FATYPE","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"3688511","version":"1","preferredName":"Malignant Neoplasm Neuroendocrine Function Assessment","preferredDefinition":"information related to the functional assessment of a tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.","longName":"FUNCTASSESS","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3689370","version":"1","preferredName":"Neuroendocrine Neoplasm Function Assessment","preferredDefinition":"A benign or malignant neoplasm composed of cells of neuroendocrine origin.  Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.:Function; what something is used for.:Having determined the value, significance, or extent of.","longName":"C3809:C25518:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Neoplasm","conceptCode":"C3809","definition":"An epithelial neoplasm with neuroendocrine differentiation. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Function","conceptCode":"C25518","definition":"The normal action performed by a structure or device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D62FBF6E-270B-6A35-E040-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2013-02-20","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-20","modifiedBy":"ONEDATA","dateModified":"2013-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6087774-6C8F-B30B-E040-BB89AD434EBC","latestVersionIndicator":"Yes","beginDate":"2013-02-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to Alliance for by script Fri Oct 25 15:25:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3688512","version":"1","preferredName":"Malignant Neoplasm Neuroendocrine Function Type","preferredDefinition":"the type of neuroendocrine malignant neoplasm.","longName":"3688512v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Functional tumor","valueDescription":"Functional Pancreatic Neuroendocrine Tumor","ValueMeaning":{"publicId":"3689372","version":"1","preferredName":"Functional Pancreatic Neuroendocrine Tumor","longName":"3689372","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  It is characterized by the presence of a clinical syndrome that results from hormone hypersecretion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Functioning Pancreatic Neuroendocrine Tumor","conceptCode":"C45840","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas. It is characterized by the presence of a clinical syndrome that results from hormone hypersecretion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D62FBF6E-2755-6A35-E040-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2013-02-20","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D62FBF6E-276E-6A35-E040-BB89AD4339C1","beginDate":"2013-02-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-20","modifiedBy":"ONEDATA","dateModified":"2013-02-20","deletedIndicator":"No"},{"value":"Non-functional tumor","valueDescription":"Non-Functional Pancreatic Neuroendocrine Tumor","ValueMeaning":{"publicId":"3689374","version":"1","preferredName":"Non-Functional Pancreatic Neuroendocrine Tumor","longName":"3689374","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  It is characterized by the absence of a hormone-related clinical syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Functioning Pancreatic Neuroendocrine Tumor","conceptCode":"C45837","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas.  It is characterized by the absence of a hormone-related clinical syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D62FBF6E-277B-6A35-E040-BB89AD4339C1","latestVersionIndicator":"Yes","beginDate":"2013-02-20","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D62FBF6E-2794-6A35-E040-BB89AD4339C1","beginDate":"2013-02-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-20","modifiedBy":"ONEDATA","dateModified":"2013-02-20","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66DB9B5D-4E8B-3285-E053-F662850AF5EB","beginDate":"2018-03-08","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-03-08","modifiedBy":"ONEDATA","dateModified":"2018-03-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6087774-6CA1-B30B-E040-BB89AD434EBC","latestVersionIndicator":"Yes","beginDate":"2013-02-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-18","modifiedBy":"MORENOC","dateModified":"2018-03-08","changeDescription":"Changed from CTEP to Alliance for by script Fri Oct 25 15:25:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"FATYPE","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Tumor type","type":"Preferred Question Text","description":"Tumor type","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Functional status","url":null,"context":"Alliance"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6087774-6CFC-B30B-E040-BB89AD434EBC","latestVersionIndicator":"Yes","beginDate":"2013-02-18","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-02-18","modifiedBy":"MORENOC","dateModified":"2018-03-08","changeDescription":" Changed from CTEP to Alliance for by script Fri Oct 25 15:25:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}